NurseCe4Less.com

Observational, open-label study of convalescent plasma expanded access program (EAP) by Mayo Clinic that included 35,322 hospitalized patients with/at risk of severe COVID-19 at 2,807 acute care facilities. Patients received at least one unit of human convalescent plasma donated by COVID-19 survivors. The primary outcome was 7 and 30-day mortality. ................
................